|
Investigating the effect of hydro-alcoholic extract of Salix aegyptiaca on anxiety in male rat
Alireza Komaki1, Nasrin Hashemi-Firouzi1, Sahar Kakaei2, Siamak Shahidi1, Abdolrahman Sarihi1, Iraj Salehi1
1 Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Physiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
| Date of Submission | 30-Dec-2013 |
| Date of Acceptance | 25-Oct-2014 |
| Date of Web Publication | 30-Nov-2015 |
Correspondence Address:
Alireza Komaki
Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2277-9175.170683
Background: Anxiety disorders are frequently common neuropsychiatric disorders. Herbal medicines are widespread and used universal as a treatment compound for anxiety. The present study investigated the effects of hydro-alcoholic extract of Salix aegyptiaca blossom on rat behavior in the elevated plus-maze (EPM) and compared results with the effects of diazepam, as a positive control drug.
Materials and Methods: Seventy adult male Wistar rats were divided into seven groups (N = 10). Animals received S. aegyptiaca extract (25, 50, 100 mg/kg) or Diazepam (0.3, 0.6, or 1.2 mg/kg) intraperitoneally and the control group was given the vehicle (10 ml/kg) 30 min before submitting into plus-maze test. The number of entries into the open and closed arms, the percentage of entries into the open arms of the EPM, and the time spent in the open arms were recorded.
Results: The results revealed significant increases in percentage of entries into the open arms (P < 0.01) and in the time spent in the open arms (P < 0.01) after administration of diazepam (0.3, 0.6) and S. aegyptiaca (50, 100 mg/kg) in compare with control group. S. aegyptiaca extract has no effects on the total distance covered by animals and number of closed arms entries, whereas diazepam decreased these parameters. The locomotor activity was not significantly changed by S. aegyptiaca.
Conclusion: Single-session administration of optimum doses of total extract of S. aegyptiaca has anxiolytic effects in rat similar to the low dose of diazepam. More research is needed for better understanding of anxiolytic properties and neurobiological mechanisms of action and probable interactions of S. aegyptiaca extract with neurotransmitters. Keywords: Anxiety, Salix aegyptiaca, diazepam, elevated plus maze, rat
How to cite this article:
Komaki A, Hashemi-Firouzi N, Kakaei S, Shahidi S, Sarihi A, Salehi I. Investigating the effect of hydro-alcoholic extract of Salix aegyptiaca on anxiety in male rat. Adv Biomed Res 2015;4:258 |
How to cite this URL:
Komaki A, Hashemi-Firouzi N, Kakaei S, Shahidi S, Sarihi A, Salehi I. Investigating the effect of hydro-alcoholic extract of Salix aegyptiaca on anxiety in male rat. Adv Biomed Res [serial online] 2015 [cited 2023 Mar 26];4:258. Available from: https://www.advbiores.net/text.asp?2015/4/1/258/170683 |
| Introduction | |  |
Anxiety is among the most common, most treatable mental disorders. Emotional, cognitive, behavioral and physical components all can be present in anxiety. Anxiety affects one-eighth of the total population word-wide and has become an important area of research interest in psychopharmacology during this decade.[1] Benzodiazepines are the major class of compounds used in anxiety and they have remained the most commonly prescribed treatment for anxiety.[2] Although the benzodiazepines have been known as an effective treatment for anxiety disorders but they cause several undesirable side effects. Therefore, many researches are necessary to find new anxiolytic drugs with less adverse effects.[2],[3],[4],[5]
Salix aegyptiaca, a plant well-known as Musk Willow, is a member of Salicaceae family.[6] In Iranian traditional medicine, S. aegyptiaca (Bidmeshk in Persian), has been used for a long time for treating inflammation, gastrodynia, osteodynia palpitation, heart failure and also it is suggested for neurological disorders.[7],[8],[9],[10]
There is a variety of animal tests for the investigation of anxiolytic or anxiogenic effects of substances.[11],[12] Behavior in the elevated plus-maze (EPM) is a model of anxiety for rodents and it may serve as a new basis for developing anxiolytic agents and investigating psychological and neurochemical factors of anxiety.[13],[14],[15] Rats were allowed to freely explore two elevated open and two elevated closed arms of the EPM apparatus that has been confirmed applicable to rats and mice. According to Barrett (1991), an anxiolytic effect is suggested when the drug increases open arms entries without altering the total number of arm entries.[12],[13],[14],[16] An increase of the time and the proportion of the entrances into the open arms without a changed locomotor activity are regarded as a powerful marker for an anxiolytic substance effect.[15] Locomotor activity of the animals was assessed by measuring the total distance travelled by the animal.[17],[18],[19],[20]
Pharmaceutical studies of S. aegyptiaca have shown its antioxidant,[9],[21] anti-inflammatory, analgesic and anti hyperchlosterolemic effects.[9],[10],[22] There is an evidence for anxiolytic activity from flowers extract of S. aegyptiaca in optimal doses in mice.[23]
In order to more precisely extrapolate these findings for treatment of anxiety, research using behavioral, in rat species is beneficial. On the basis of these considerations the purpose of this study was to characterize the anxiolytic-like activity of the hydro-alcoholic extract prepared from the blossom of S. aegyptiaca on rat behavior in the EPM and compared results with the effects of diazepam. The diazepam (as a benzodiazepine) is a standard anxiolytic and is also employed in behavioral pharmacology.[5],[24],[25] Benzodiazepines have been the most extensively used anxiolytics for many years.[2],[5] Diazepam is known to be anxiolytic in humans and reduced anxiety-like behavior in several animal models of behavior.[4],[16],[26]
| Materials and Methods | | |
Experimental animals
Male Wistar rat weighing 240–300 g were purchased from Razi institute, Tehran, Iran. These animals were transported to a room adjacent to the test laboratory 72 h before starting the experiments. They were housed in groups of four per cage under a 12:12 dark/light cycle (lights on at 07:00 AM) at 23 ± 2°C and given free access to food and water. Rats were randomly assigned to different treatment groups (N = 10). Animals were tested under the same experimental conditions. All experiments were carried out in a quiet room under controlled light conditions between 11:00 AM and 3:00 PM. Behavioral observations took place in soundproof rooms at the same period of the day to reduce the confounding influence of diurnal variation in spontaneous behavior. Each animal was tested only once. All research and animal care procedures were approved by the Veterinary Ethics Committee of the Hamadan University of Medical Sciences and were performed in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1985). The minimum number of animals and duration of observation required to obtain consistent data were employed.
Drugs and preparation of the extract
The blossom of S. aegyptiaca collected in the spring, and identified at the Botanic Institute of Hamadan University of Medical Sciences (plant code number: 1537/12; faculty of Pharmacy, Central Herbarium of Hamadan University of Medical Sciences). The plant material was dried at 40°C with air circulation, ground, and extracted with 70% ethanol by percolation at room temperature. The extracts were dried at 40°C under vacuum and finally freeze-dried.[27],[28] The pharmacological assays were carried out with aqueous suspensions of the dried extract. The doses are expressed as mg of dried extract/kg of rat body weight.
Diazepam (Sigma-Aldrich) was diluted with deionized water containing 0.5% propylene glycol (Sigma-Aldrich) and administrated in different doses (0.3, 0.6 and 1.2 mg/kg). Three different concentrations (25, 50, 100 mg/kg) of the S. aegyptiaca extract were prepared by dissolving the extracts in 10 ml deionized water with 0.5% propylene glycol to form a homogeneous suspension. All compounds were administrated intraperitonealy (i.p.) 30 min before placing in EPM session.
Elevated plus maze
Anxiolytic activity of extract was measured using the EPM apparatus. This test has been widely validated to measure anxiety in rodents.[13],[14],[15] Briefly, for rats, the apparatus consisted of two open arms (50 × 10 × 1 cm 3 each), two enclosed arms (50 × 10 × 50 cm 3 each) and a central platform (10 × 10 cm 2), arranged in such a way that the two arms of each type were opposite to each other. The maze was elevated 100 cm above the floor. Thirty minutes after the i.p. injection of the extract (25, 50, 100 mg/kg) or diazepam (0.3, 0.6 and 1.2 mg/kg) or the solvent (10 ml/kg), each animal was placed at the center of the maze facing one of the enclosed arms. During the 10 min test period the number of open and enclosed arms entries, the time spent in open and enclosed arms [15],[16] and the percentage of entries into the open arms were recorded.[28] Entry into an arm was defined when the animal places all four paws onto the arm.[15],[16]
Animal behavior was tracked by using a video camera located above the maze. Two 100 W lamps brightly illuminated the arena. The experimental sessions were recorded by video camera interfaced with a monitor and a VCR in an adjacent room. This apparatus allowed the measurement of activity (i.e. movement time spent) or time and distances covered in each part of the maze during test. In order to record displacements and other behaviors, the image of the elevated plus-maze was divided into 10 cm squares in a transparent mask placed on the TV screen. This allowed recording of the behavioral category end-arm exploration when the animal reaches the extremity of the open arms.[14],[15] After the test, the maze was carefully cleaned with a wet tissue paper (10% ethanol solution).
Statistical analysis
The data of following parameters were analyzed in our study: Total time spent in the open arms compare to total time in EPM, number of entries into the closed arms, percentage of entries into the open arms compare to total entries in EPM as a whole. The recorded videotapes were analyzed by a person not involved in the experimental procedure.[13] Calculation of the percentage time and number of entries on the open arms with 95% confidence limits and comparisons of the results were performed using computerized analysis. The statistical analysis of data were performed by one-way analysis of variance (ANOVA) followed by Tukey's post hoc test. In all cases differences were considered significant if P < 0.05.
| Results | | |
An IP injection of diazepam before EPM trial significantly increased the percentage of open arm entries and the time spent in the open arms. This substance decreased the total distance covered by the animals and the number of closed arm entries.[25]
The total distance covered by the S. aegyptiaca extract treated rats during the 10 min test was not significantly different from controls [Figure 1]a. The ANOVA revealed a significant effect of S. aegyptiaca extract treatment on open arms exploration. Tukey's post hoc test showed that, S. aegyptiaca has a significant increase in percentage of entries into the open arms in concentrations of 50 mg/kg (P < 0.05) and 100 mg/kg (P < 0.01), but not at 25 mg/kg in compare to the control group [Figure 1]b. In addition, the extract-treated group spent more time in the open arms in the doses of 50 (P < 0.05) and 100 mg/kg (P < 0.01), but not at 25 mg/kg [Figure 1]c. The number of entries into the closed arms was not significantly different between the S. aegyptiaca-treated and control groups [Figure 1]d. | Figure 1: The effects of salix aegyptiaca extract (25, 50, 100 mg/kg, i.p.) on total distance covered by rats (A), the percentage of entries in the open arms (B), time spent in the open arms (C) and number of closed arms entry (D) during the 10 min test session in EPM. Data represent mean±SEM (n=10). Comparisons were made using one-way ANOVA followed by post hoc Tukey's test. *: P<0.05, **: P<0.01 in compare with control group
Click here to view |
| Discussion | | |
The present study investigated the behavioral effects of the hydro-alcoholic extract of the S. aegyptiaca blossom. Our results demonstrated that the extract is able to produce anxiolytic effect in rats. In the other word, the extract of S. aegyptiaca (50 or 100 mg/kg, i.p.) increased both of the percentages of entries and time spent in the open arms of the maze, similar to the effects observed after the reference anxiolytic drug diazepam. The effect of S. aegyptiaca was not induced by changes in motor activity for such doses, because the total distance traveled by the rats was not altered.
Diazepam was applied as anxiolytic positive control drug.[25],[29],[30],[31] Amount of closed arm entry indicates the animal locomotion activity.[32] In this method high dose of diazepam could not induce anxiolytic effect because it reduces animal locomotion activity in result of severe sedative effect.
S. aegyptiaca extract did not induce changes in motor activity in their anxiolytic doses. In the other word, the total distance covered by the rats was not altered. The high dose of 100 mg/kg induced the most marked effects and raised the anxiolytic behavior. In the other word, extract-treated rats showed a significant increase of both the percentage of entries and the percentage of time spent in the open arms of the maze, similar to the effects observed after the reference anxiolytic drug diazepam. The results of this experiment are consistent with an anxiolytic-like activity from the extract of S. aegyptiaca in mice.[23] In addition of animal model, the manner of extract administration in the two studies was different. In the previous study, the mice had treated by subcutaneous and oral administration extract of the flower parts of the plant at doses of 100 and 200 mg/kg. Also, the results of extract effects on animal locomotion in the two studies were different. It has been reported that S. aegyptiaca can increase the percentage of time spent in the open arms of the EPM.[23] An increase of the time and the proportion of the entrances into the open arms lacking a changed locomotors activity are confirmed as a potent sign for an anxiolytic substance effect.[15]
Recently, antioxidant activity of S. aegyptiaca has been reported.[21] Extensive research has been conducted to reveal multiple neural substrates and mechanisms that contribute to the etiology of depression and anxiety, among which the imbalance between oxidation and antioxidant defense system have gained attention.[33] Some studies have demonstrated the role of oxidative stress in anxiety of rodents.[34],[35],[36] Furthermore, it has been recently reported that two agents that induce oxidative stress, l-buthionine-(S, R)-sulfoximine (BSO) or xanthine plus xanthine oxidase (X + XO), cause increased anxiety-like behavior in rats.[37],[38],[39] Also, increasing evidence suggests that the impairment of antioxidant defense and the neuronal cell death are important in the process of emotional disorders, such as depression and anxiety.[33] According to this, Masood et al. (2008) reported that the induction of oxidative stress in mice hypothalamus occurs in parallel with anxiety.[36] The consumption of diets with high levels of sucrose was reported to increase the oxidation of proteins in frontal cortex and to cause anxiety in rats. Increased anxiety has been positively correlated with the increase of ROS levels. In another study, oxidative stress in hippocampus of adult rats was reported to be anxiogenic.[40],[41] Interestingly, the induction of oxidative stress by a nonpharmacological method also leads to anxiety like behavior in rats.[37] Moreover, the increase in anxiety-like behavior is reversed by antioxidant tempol treatment, suggesting direct involvement of oxidative stress in mediating anxiety-like behavior of rats.[38]
The pharmacological mechanism of S. aegyptiaca is suggested to nerve tonic and laxative actions.[10]S. aegyptiaca contains phytochemicals compounds such as flavonoids, phenolics, volatile, endogenous salicin, myricetin, kaempferol, quercetin, rutin and luteolin.[9],[10],[21],[23],[42] The high amounts of phenols and flavonoids in S. aegyptiaca extracts may be responsible for its anxiolytic effects. However, the exact mechanism(s) and the active compound(s) involved in anxiolytic property have not been fully clarified and further biochemical and pharmacological studies are warranted.
| Conclusion | | |
In conclusion, our results demonstrate that acute administration of hydro-alcoholic extract of S. aegyptiaca produced the anxiolytic properties due to their active components and did not change the locomotion activities in rat. Possibly, the anxiolytic activity observed in this work is dependent on the phenols, flavonoid or other substances with antioxidant activity in S. aegyptiaca extract. Future work will be needed to find the active compound (s) and the neurobiological mechanisms as well as probable interactions of S. aegyptiaca extract with neurotransmitters systems.
| Acknowledgments | | |
This study was supported by Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
| References | | |
| 1. | Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. JAMA 1998;280:1569-75.  |
| 2. | Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: Are they justified? Eur Neuropsychopharmacol 1999;9:399-405. |
| 3. | Lader M, Morton S. Benzodiazepine problems. Br J Addict 1991;86:823-8. |
| 4. | Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of triazolam: Experimental measurements in animals and humans. Psychopharmacol Ser 1987;3:83-7. [ PUBMED] |
| 5. | Holm M. One year follow-up of users of benzodiazepines in general practice. Dan Med Bull 1990;37:188-91. |
| 6. | Zargari A. Medicinal Plants. 1 st ed, Vol. 3. Tehran, Iran: Tehran University Press; 1990. p. 355-61. |
| 7. | Ave-Sina A. Law in Medicine. Tehran, Iran; Bermejo Benito: Soroosh Press; 1988. |
| 8. | Aqili Khorasani MH. Collection of Drugs (Materia Media). Tehran, Iran: Enqelab-e-Eslami Publishing and Educational Organization; 1991. p. 388-9. |
| 9. | Sonboli A, Mojarrad M, Nejad Ebrahimi S, Enayat S. Free radical scavenging activity and total phenolic content of methanolic extracts from male inflorescence of Salix aegyptiaca grown in Iran. Iran J Pharm Res 2010;9:293-6. [ PUBMED] |
| 10. | Karimi I, Hayatgheybi H, Shamspur T, Kamalak A, Pooyanmehr M, Marandi Y. Chemical composition and effect of an essential oil of Salix aegyptiaca (musk willow) in hypercholesterolemic rabbit model. Braz J Pharmacog 2011;21:407-14. |
| 11. | Stephens DN, Andrews JS. Screening for anxiolytic drugs. In: Willner P, ed. Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. Cambridge: Cambridge University Press; 1991. |
| 12. | Barrett JE. Animal behavior models in the analysis and understanding of anxiolytic drugs acting at serotonin receptors. In: Olivier B, Mos J, Slangen JL, editors. Animal models in psychopharmacology. Switzerland: Basel Birkhauser Verlag; 1991. p. 37-52. |
| 13. | Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety like behavior: The elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005;29:1193-205. |
| 14. | Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987;92:180-5. [ PUBMED] |
| 15. | Pellow S, Chopin P, File SE, Briley M. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14:149-67. [ PUBMED] |
| 16. | Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol Biochem Behav 1986;24:526-30. |
| 17. | Burghardt PR, Wilson MA. Microinjection of naltrexone into the central, but not the basolateral, amygdala blocks the anxiolytic effects of diazepam in the plus maze. Neuropsychopharmacology 2006;31:1227-40. |
| 18. | Yildiz Akar F, Ulak G, Tanyeri P, Erden F, Utkan T, Gacar N. 7-Nitroindazole, a neuronal nitric oxide synthase inhibitor, impairs passive-avoidance and elevated plus-maze memory performance in rats. Pharmacol Biochem Behav 2007;87:434-43. |
| 19. | Bacchi F, Mathé AA, Jiménez P, Stasi L, Arban R, Gerrard P, et al. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides 2006;27:3202-7. |
| 20. | Drapier D, Bentué-Ferrer D, Laviolle B, Millet B, Allain H, Bourin M, et al. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 2007;176:202-9. |
| 21. | Enayat S, Banerjee S. Comparative antioxidant activity of extracts from leaves, bark and catkins of Salix aegyptiaca. Food Chem 2009;116:23-8. |
| 22. | Karawya MS, Ammar MN, Hifnawy MS, Al-Okbi SY, Mohamed DA, El- Anssary AA. Phytochemical study and evaluation of the anti-inflammatory activity of some medicinal plants growing in Egypt. Med J Islamic World Acad Sci 2010;18:139-50. |
| 23. | Rabbani M, Sajjadi SE, Rahimi F. Anxiolytic effect of flowers of Salix aegyptiaca L. in mouse model of anxiety. J Complementary Integr Med 2010;7:18-22. |
| 24. | Green S. Benzodiazepines, putative anxiolytics and animal models of anxiety. Trends Neurosci 1991;14:101-4. |
| 25. | Komaki A, Abdollahzadeh F, Sarihi A, Shahidi S, Salehi I. Interaction between antagonist of cannabinoid receptor and antagonist of adrenergic receptor on anxiety in male rat. Basic Clin Neurosci. 2014;5:218-24. |
| 26. | Wilson MA, Burghardt PR, Ford KA, Wilkinson MB, Primeaux SD. Anxiolytic effects of diazepam and ethanol in two behavioral models: Comparison of males and females. Pharmacol Biochem Behav 2004;78:445-58. |
| 27. | Silva LF, Lima ES, Vasconcellos MC, Aranha ES, Costa DS, Mustafa EV, et al. In vitro and in vivo antimalarial activity and cytotoxicity of extracts, fractions and a substance isolated from the Amazonian plant Tachia grandiflora (Gentianaceae). Mem Inst Oswaldo Cruz 2013;108:501-7. |
| 28. | Asami DK, Hong YJ, Barrett DM, Mitchell AE. Comparison of the total phenolic and ascorbic acid content of freeze-dried and air-dried marionberry, strawberry, and corn grown using conventional, organic, and sustainable agricultural practices. J Agric Food Chem 2003;51:1237-41. |
| 29. | Rex A, Morgenstern E, Fink H. Anxiolytic-like effects of Kava-Kava in the elevated plus maze test – A comparison with diazepam. Prog Neuropsychopharmacol Biol Pschiatry 2002;26:855-8. |
| 30. | Souto-Maior FN, de Carvalho FL, de Morais LC, Netto SM, de Sousa DP, de Almeida RN. Anxiolytic-like effects of inhaled linalool oxide in experimental mouse anxiety models. Pharma Bio Behav 2011;100:259-63. |
| 31. | Gomes PB, Feitosa ML, Silva MI, Noronha EC, Moura BA, Venâncio ET, et al. Anxiolytic-like effect of the monoterpene 1,4-cineole in mice. Pharmaco Bioche Behav 2010;96:287-93. |
| 32. | Takahashi RN, Berton O, Mormède P, Chaouloff F. Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze. Braz J Med Biol Res 2001;34:675-82. |
| 33. | Ding L, Zhang C, Masood A, Li J, Sun J, Nadeem A, et al. Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: Involvement of antioxidant and anti-apoptotic mechanisms. Behav Brain Res 2014;268:150-8. |
| 34. | de Almeida AA, de Carvalho RB, Silva OA, de Sousa DP, de Freitas RM. Potential antioxidant and anxiolytic effects of (+)-limonene epoxide in mice after marble-burying test. Pharmacol Biochem Behav 2014;118:69-78. |
| 35. | Oliveira MR, Silvestrin RB, Mello E, Souza T, Moreira JC. Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: Effects of sub acute vitamin A supplementation at therapeutic doses. Neurotoxicology 2007;28:1191-9. |
| 36. | Masood A, Nadeem A, Mustafa SJ, O'Donnell JM. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther 2008;326:369-79. |
| 37. | Vollert C, Zagaar M, Hovatta I, Taneja M, Vu A, Dao A, et al. Exercise prevents sleep deprivation-associated anxiety-like behavior in rats: Potential role of oxidative stress mechanisms. Behav Brain Res 2011;224:233-40. |
| 38. | Salim S, Sarraj N, Taneja M, Saha K, Tejada-Simon MV, Chugh C. Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats. Behav Brain Res 2010;208:545-52. |
| 39. | Salim S, Asghar M, Chugh G, Taneja M, Xia Z, Saha K. Oxidative stress: A potential recipe for anxiety, hypertension and insulin resistance. Brain Res 2010;1359:178-85. |
| 40. | Souza CG, Moreira JD, Siqueira IR, Pereira AG, Rieger DK, Souza DO, et al. Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci 2007;81:198-203. |
| 41. | Bouayed J, Rammal H, Younos C, Soulimani R. Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice. Eur J Pharmacol 2007;564:146-9. |
| 42. | Nahrstedt A, Schmidt M, Jäggi R, Metz J, Khayyal MT. Willow bark extract: The contribution of polyphenols to the overall effect. Wien Med Wochenschr 2007;157:348-51. |
[Figure 1]
| This article has been cited by | | 1 |
Catechin mediated green synthesis of Au nanoparticles: Experimental and theoretical approaches to the determination HOMO-LUMO energy gap and reactivity indexes for the (+)-epicatechin (2S, 3S) |
|
| Javad Ebrahimian, Maryam Khayatkashani, Nasrin Soltani, Qahtan A. Yousif, Masoud Salavati-Niasari | | Arabian Journal of Chemistry. 2022; 15(5): 103758 | | [Pubmed] | [DOI] | | | 2 |
The effects of cinnamaldehyde on acute or chronic stress-induced anxiety-related behavior and locomotion in male mice |
|
| Farshid Etaee,Alireza Komaki,Nafiseh Faraji,Arezoo Rezvani-Kamran,Somayeh Komaki,Parisa Hasanein,Mohammad Taheri,Ghazaleh Omidi | | Stress. 2019; : 1 | | [Pubmed] | [DOI] | | | 3 |
Effects of Hypericum Scabrum extract on anxiety and oxidative stress biomarkers in rats fed a long-term high-fat diet |
|
| Ahmad Ganji,Iraj Salehi,Abdolrahman Sarihi,Siamak Shahidi,Alireza Komaki | | Metabolic Brain Disease. 2016; | | [Pubmed] | [DOI] | |
|
 |
|
|
|
Search Pubmed for